This study pooled data from 4 registries to analyze the clinical impact of intravascular ultrasound (IVUS) guidance in drug-eluting stent implantation for unprotected left main coronary disease. The study included 1,759 patients, 935 who received IVUS guidance and 824 who received angiography guidance alone. The primary endpoint was the composite of death, myocardial infarction, or target vessel revascularization. At 2 years of follow-up, IVUS guidance was associated with lower rates of the primary endpoint compared to angiography guidance alone (13.5% vs 17.7%). IVUS guidance also reduced the risk of stent thrombosis. The study demonstrates the benefits of IVUS guidance for optimizing stent implantation in complex unprotected left
XXVII Reunión anual de la sección de Hemodinámica y Cardiología Intervencionista
16 y 17 de junio de 2016 León
http://secardiologia.es/xxvii-reunion-anual-de-la-seccion-de-hemodinamica-y-cardiologia-intervencionista
Aportaciones del grupo CORPAL en intervencionismo coronario
Alfonso Medina Fernández-Aceytuno (Hosp. Univ. Doctor Negrín. Las Palmas de Gran Canaria)
XXVII Reunión anual de la sección de Hemodinámica y Cardiología Intervencionista
16 y 17 de junio de 2016 León
http://secardiologia.es/xxvii-reunion-anual-de-la-seccion-de-hemodinamica-y-cardiologia-intervencionista
TORO. Registro Español de Oclusión Crónica total secundaria a restenosis oclusiva intrastent
José R. Rumoroso
XXVII Reunión anual de la sección de Hemodinámica y Cardiología Intervencionista
16 y 17 de junio de 2016 León
http://secardiologia.es/xxvii-reunion-anual-de-la-seccion-de-hemodinamica-y-cardiologia-intervencionista
Novedades en farmacología en intervencionismo
Antonio Fernández Ortiz (Hosp. Clínico San Carlos. Madrid)
XXVII Reunión anual de la sección de Hemodinámica y Cardiología Intervencionista
16 y 17 de junio de 2016 León
http://secardiologia.es/xxvii-reunion-anual-de-la-seccion-de-hemodinamica-y-cardiologia-intervencionista
REPARA. Registro de paciEntes con dispositivo biorreabsorbible en la Práctica clínica habitual
XXVII Reunión anual de la sección de Hemodinámica y Cardiología Intervencionista
16 y 17 de junio de 2016 León
http://secardiologia.es/xxvii-reunion-anual-de-la-seccion-de-hemodinamica-y-cardiologia-intervencionista
Aportaciones del grupo CORPAL en intervencionismo coronario
Alfonso Medina Fernández-Aceytuno (Hosp. Univ. Doctor Negrín. Las Palmas de Gran Canaria)
XXVII Reunión anual de la sección de Hemodinámica y Cardiología Intervencionista
16 y 17 de junio de 2016 León
http://secardiologia.es/xxvii-reunion-anual-de-la-seccion-de-hemodinamica-y-cardiologia-intervencionista
TORO. Registro Español de Oclusión Crónica total secundaria a restenosis oclusiva intrastent
José R. Rumoroso
XXVII Reunión anual de la sección de Hemodinámica y Cardiología Intervencionista
16 y 17 de junio de 2016 León
http://secardiologia.es/xxvii-reunion-anual-de-la-seccion-de-hemodinamica-y-cardiologia-intervencionista
Novedades en farmacología en intervencionismo
Antonio Fernández Ortiz (Hosp. Clínico San Carlos. Madrid)
XXVII Reunión anual de la sección de Hemodinámica y Cardiología Intervencionista
16 y 17 de junio de 2016 León
http://secardiologia.es/xxvii-reunion-anual-de-la-seccion-de-hemodinamica-y-cardiologia-intervencionista
REPARA. Registro de paciEntes con dispositivo biorreabsorbible en la Práctica clínica habitual
Presentación "Cardiopatía Estructural" del Dr. José María Hernández durante la Mesa Redonda "Novedades en cardiología Intervencionista del último Congreso a este" de la XXV Reunión Anual de la Sección de Hemodinámica y Cardiología Intervencionista (SHCI) de 2014 en Córdoba.
Presentación "Estenosis aórtica riesgo moderado" del Lino Patricio durante la Mesa Redonda Hispano-Lusa sobre Controversias de la XXV Reunión Anual de la Sección de Hemodinámica y Cardiología Intervencionista (SHCI) de 2014 en Córdoba.
Presentación "Update de los estudios de ABSORB hasta 2014" del Dr. Flavio Ribichini durante la Mesa Redonda sobre Scaffolds reabsorbibles de la XXV Reunión Anual de la Sección de Hemodinámica y Cardiología Intervencionista (SHCI) de 2014 en Córdoba.
Conferencia magistral "20 años de Angioplastia Primaria para el tratamiento del Infarto. Experiencia y evolución de las redes de infarto" del Dr. Petr Widimsky durante la XXV Reunión Anual de la Sección de Hemodinámica y Cardiología Intervencionista (SHCI) de 2014 en Córdoba.
Presentación "Cardiopatía Estructural" del Dr. José María Hernández durante la Mesa Redonda "Novedades en cardiología Intervencionista del último Congreso a este" de la XXV Reunión Anual de la Sección de Hemodinámica y Cardiología Intervencionista (SHCI) de 2014 en Córdoba.
Presentación "Estenosis aórtica riesgo moderado" del Lino Patricio durante la Mesa Redonda Hispano-Lusa sobre Controversias de la XXV Reunión Anual de la Sección de Hemodinámica y Cardiología Intervencionista (SHCI) de 2014 en Córdoba.
Presentación "Update de los estudios de ABSORB hasta 2014" del Dr. Flavio Ribichini durante la Mesa Redonda sobre Scaffolds reabsorbibles de la XXV Reunión Anual de la Sección de Hemodinámica y Cardiología Intervencionista (SHCI) de 2014 en Córdoba.
Conferencia magistral "20 años de Angioplastia Primaria para el tratamiento del Infarto. Experiencia y evolución de las redes de infarto" del Dr. Petr Widimsky durante la XXV Reunión Anual de la Sección de Hemodinámica y Cardiología Intervencionista (SHCI) de 2014 en Córdoba.
Coronary artery bypass grafting with adjunctive
endarterectomy: A mandatory procedure in complex
revascularizations. current results and postoperative
considerations
The past ESC President Prof. Fausto Pinto together with the ESC Board, previously asked all its constituent bodies to aim for a minimum of 25% female representation by 2018 on the task forces, committees, nuclei and boards of our associations, councils and working groups. The current ESC President and Vice President, Prof. Jeroen Bax and Prof. Lina Badimon, sent in April an official letter to recognize that the field of cardiology is becoming more gender-balanced, encouraging further commitment and support.
Epistemic Interaction - tuning interfaces to provide information for AI supportAlan Dix
Paper presented at SYNERGY workshop at AVI 2024, Genoa, Italy. 3rd June 2024
https://alandix.com/academic/papers/synergy2024-epistemic/
As machine learning integrates deeper into human-computer interactions, the concept of epistemic interaction emerges, aiming to refine these interactions to enhance system adaptability. This approach encourages minor, intentional adjustments in user behaviour to enrich the data available for system learning. This paper introduces epistemic interaction within the context of human-system communication, illustrating how deliberate interaction design can improve system understanding and adaptation. Through concrete examples, we demonstrate the potential of epistemic interaction to significantly advance human-computer interaction by leveraging intuitive human communication strategies to inform system design and functionality, offering a novel pathway for enriching user-system engagements.
Dev Dives: Train smarter, not harder – active learning and UiPath LLMs for do...UiPathCommunity
💥 Speed, accuracy, and scaling – discover the superpowers of GenAI in action with UiPath Document Understanding and Communications Mining™:
See how to accelerate model training and optimize model performance with active learning
Learn about the latest enhancements to out-of-the-box document processing – with little to no training required
Get an exclusive demo of the new family of UiPath LLMs – GenAI models specialized for processing different types of documents and messages
This is a hands-on session specifically designed for automation developers and AI enthusiasts seeking to enhance their knowledge in leveraging the latest intelligent document processing capabilities offered by UiPath.
Speakers:
👨🏫 Andras Palfi, Senior Product Manager, UiPath
👩🏫 Lenka Dulovicova, Product Program Manager, UiPath
Accelerate your Kubernetes clusters with Varnish CachingThijs Feryn
A presentation about the usage and availability of Varnish on Kubernetes. This talk explores the capabilities of Varnish caching and shows how to use the Varnish Helm chart to deploy it to Kubernetes.
This presentation was delivered at K8SUG Singapore. See https://feryn.eu/presentations/accelerate-your-kubernetes-clusters-with-varnish-caching-k8sug-singapore-28-2024 for more details.
Builder.ai Founder Sachin Dev Duggal's Strategic Approach to Create an Innova...Ramesh Iyer
In today's fast-changing business world, Companies that adapt and embrace new ideas often need help to keep up with the competition. However, fostering a culture of innovation takes much work. It takes vision, leadership and willingness to take risks in the right proportion. Sachin Dev Duggal, co-founder of Builder.ai, has perfected the art of this balance, creating a company culture where creativity and growth are nurtured at each stage.
LF Energy Webinar: Electrical Grid Modelling and Simulation Through PowSyBl -...DanBrown980551
Do you want to learn how to model and simulate an electrical network from scratch in under an hour?
Then welcome to this PowSyBl workshop, hosted by Rte, the French Transmission System Operator (TSO)!
During the webinar, you will discover the PowSyBl ecosystem as well as handle and study an electrical network through an interactive Python notebook.
PowSyBl is an open source project hosted by LF Energy, which offers a comprehensive set of features for electrical grid modelling and simulation. Among other advanced features, PowSyBl provides:
- A fully editable and extendable library for grid component modelling;
- Visualization tools to display your network;
- Grid simulation tools, such as power flows, security analyses (with or without remedial actions) and sensitivity analyses;
The framework is mostly written in Java, with a Python binding so that Python developers can access PowSyBl functionalities as well.
What you will learn during the webinar:
- For beginners: discover PowSyBl's functionalities through a quick general presentation and the notebook, without needing any expert coding skills;
- For advanced developers: master the skills to efficiently apply PowSyBl functionalities to your real-world scenarios.
DevOps and Testing slides at DASA ConnectKari Kakkonen
My and Rik Marselis slides at 30.5.2024 DASA Connect conference. We discuss about what is testing, then what is agile testing and finally what is Testing in DevOps. Finally we had lovely workshop with the participants trying to find out different ways to think about quality and testing in different parts of the DevOps infinity loop.
Neuro-symbolic is not enough, we need neuro-*semantic*Frank van Harmelen
Neuro-symbolic (NeSy) AI is on the rise. However, simply machine learning on just any symbolic structure is not sufficient to really harvest the gains of NeSy. These will only be gained when the symbolic structures have an actual semantics. I give an operational definition of semantics as “predictable inference”.
All of this illustrated with link prediction over knowledge graphs, but the argument is general.
Essentials of Automations: Optimizing FME Workflows with ParametersSafe Software
Are you looking to streamline your workflows and boost your projects’ efficiency? Do you find yourself searching for ways to add flexibility and control over your FME workflows? If so, you’re in the right place.
Join us for an insightful dive into the world of FME parameters, a critical element in optimizing workflow efficiency. This webinar marks the beginning of our three-part “Essentials of Automation” series. This first webinar is designed to equip you with the knowledge and skills to utilize parameters effectively: enhancing the flexibility, maintainability, and user control of your FME projects.
Here’s what you’ll gain:
- Essentials of FME Parameters: Understand the pivotal role of parameters, including Reader/Writer, Transformer, User, and FME Flow categories. Discover how they are the key to unlocking automation and optimization within your workflows.
- Practical Applications in FME Form: Delve into key user parameter types including choice, connections, and file URLs. Allow users to control how a workflow runs, making your workflows more reusable. Learn to import values and deliver the best user experience for your workflows while enhancing accuracy.
- Optimization Strategies in FME Flow: Explore the creation and strategic deployment of parameters in FME Flow, including the use of deployment and geometry parameters, to maximize workflow efficiency.
- Pro Tips for Success: Gain insights on parameterizing connections and leveraging new features like Conditional Visibility for clarity and simplicity.
We’ll wrap up with a glimpse into future webinars, followed by a Q&A session to address your specific questions surrounding this topic.
Don’t miss this opportunity to elevate your FME expertise and drive your projects to new heights of efficiency.
"Impact of front-end architecture on development cost", Viktor TurskyiFwdays
I have heard many times that architecture is not important for the front-end. Also, many times I have seen how developers implement features on the front-end just following the standard rules for a framework and think that this is enough to successfully launch the project, and then the project fails. How to prevent this and what approach to choose? I have launched dozens of complex projects and during the talk we will analyze which approaches have worked for me and which have not.
"Impact of front-end architecture on development cost", Viktor Turskyi
Dr José María de la Torre Hernández presentación IVUS y OCT en TEAM 2013
1. Jose Mª de la Torre Hernandez
Unidad de Cardiologia Intervencionista
Hospital Universitario Marques de Valdecilla
Santander
IVUS/OCT como guía del
intervencionismo
coronario
2.
3.
4. La importancia del
diagnostico basal
Una angioplastia exitosa comienza por
una adecuada indicación y un
correcto diagnostico
6. 400 pts 400 pts
FFR IVUS
Centro-FFR vs. Centro-IVUSCentro-FFR vs. Centro-IVUS
(De la Torre Hernandez, Lopez Palop, et al. )
FFR < 0.75
MLA < 3,5 - 4 mm2
(based on vessel size) and PB > 50%
EuroIntervention. 2013 May 20.
(Epub ahead of print)
7. 11 estudios , incluyendo 2 en tronco (TC)
(total N= 1759 pacientes, 1953 lesiones)
El corte ponderado medio fue 2.6 mm2
en estudios no-TC y de
5.5 mm2
en estudios en TC
En lesiones no-TC, el ALM mostro:
Sensibilidad = 79%
Especificidad = 65%
En lesiones de TC el ALM mostro:
Sensibilidad = 90%
Especificidad = 90%
Precision diagnostica del ALM obtenido por
IVS comparado con el FFR
- Meta-analisis -
8. FFR Significacion
IVUS Presencia de placa
Cantidad de placa
Reduccion luminal
Calcio
Morfologia (complicada ?)
Remodelado
Extension enfermedad (vaso total)
9.
10.
11. Lesiones intermedias
FFR
-Estenosis bien definidas 40-70%
IVUS
-Lesiones irregulares (ulceradas, disecadas...)
-Defectos contrastacion (nodulares, lineales…)
-Posibles artefactos (ostium tronco, ostium CD…)
-No bien visualizables (tri-bifurcaciones, superposiciones
de ramas,…)
13. ALM = 3 mm2
ALM = 3 mm2
ALM = 6 mm2
TC
Proximal DA
Proximal Cx
Jasti et al. Circulation
2004;110:2831-6
Linear law (epicardial coronary artery)
Do = 0.678*(D1+D2)
Finet G et al. Eurointervention 2007;3:10-17
14. De la Torre et al. J Am Coll Cardiol 2011;58(4):351-8
Validación prospectiva de ALM = 6 mm2
como corte para
revascularizacion del TC en nuestra población
354 pacientes en 22 centros
15. En que nos ayuda el IVUS para
mejorar los resultados de la ICP
16. Hematoma
Hallazgos de IVUS en el stent
Enf.
bordes
Rotura stent
Prolapso placa
Subexpansion Aposicion
Incompleta
Diseccion
en margenes
18. IVUS en reestenosis de BMS/DES :
ImplicacionesImplicaciones TerapeuticasTerapeuticas
Predomina
Subexpansion
Predomina
Prolif. intimal
Fractura
stent
19. IVUS Predictores de Trombosis y Reestenosis precoz con BMS
Trombosis
precoz
Reestenosis
SubexpansionSubexpansion •Cheneau et al.
Circulation
2003;108:43-7
•Kasaoka et al. J Am Coll Cardiol
1998;32:1630-5
•Castagna et al. AHJ 2001;142:970-4
•de Feyter et al. Circulation
1999;100:1777-83
•Sonoda et al. J Am Coll Cardiol
2004;43:1959-63
•Morino et al. Am J Cardiol 2001;88:301-
3
•Ziada et al. Am Heart J 2001;141:823-31
•Doi et al. JACC Cardiovasc Interv.
2009;2:1269-75
Problemas de bordeProblemas de borde
(“geographic miss”, carga de(“geographic miss”, carga de
placa alta, disecciones,… etc)placa alta, disecciones,… etc)
•Cheneau et al.
Circulation
2003;108:43-7
•Sakurai et al. Am J Cardiol
2005;96:1251-3
•Liu et al. Am J Cardiol 2009;103:501-6
Longitud stentLongitud stent •Kasaoka et al. J Am Coll Cardiol
1998;32:1630-5
•de Feyter et al. Circulation
1999;100:1777-83
20. Impacto de la longitud de lesion y area
minima intrastent sobre la reestenosis
de Feyter et al. Circulation 1999;100:1777-83de Feyter et al. Circulation 1999;100:1777-83
Final Minimum Stent Area (mm2
)
Stent Length
(m
m
)
Restenosis(%)
*
*
*
*
*
*
*
* *
*
*
* *
*
*
*
*
*
**
*
*
*
*
*
*
*
21. .1 1 10
TULIP
DIPOL
Gaster
RESIST
SIPS
AVID
OPTICUS
Favors Non-IVUSFavors IVUS Odds Ratio
Combined (RE)
Combined (FE)
MACE
Meta-analisis de Trials IVUS vs Angiografia
en implantacion de BMS (n=2.193 pts)
El uso de IVUS se asocio a menos:
•Reestenosis Angiografica
•(22.2% vs. 28.9%; p=0.02)
•Revascularizacion Repetida
(12.6% vs. 18.4%; p=0.004)
•MACE
•(19.1% vs. 23.1%; p=0.03)
Parise et al. Am J Cardiol. 2011;107:374-82
22. Predictores en IVUS para trombosis y reestenosis de DES
Trombosis precoz Reestenosis
SubexpansionSubexpansion •Fujii et al. J Am Coll Cardiol 2005;45:995-
8)
•Okabe et al., Am J Cardiol. 2007;100:615-
20
•Liu et al. JACC Cardiovasc Interv.
2009;2:428-34
•Choi et al. Circ Cardiovasc Interv
2011;4:239-47
•Sonoda et al. J Am Coll Cardiol
2004;43:1959-63
•Hong et al. Eur Heart J
2006;27:1305-10
•Doi et al JACC Cardiovasc Interv.
2009;2:1269-75
•Fujii et al. Circulation
2004;109:1085-1088
•Kang et al. Circ Cardiovasc Interv
2011;4:9-14
•Choi et al. Am J Cardiol
2012;109:455-60
•Song et al. Catheter Cardiovasc
Interv, in press
Problemas de bordeProblemas de borde
(“geographic miss”,(“geographic miss”,
carga de placa alta,carga de placa alta,
disecciones,… etc)disecciones,… etc)
•Fujii et al. J Am Coll Cardiol 2005;45:995-
8
•Okabe et al., Am J Cardiol. 2007;100:615-
20
•Liu et al. JACC Cardiovasc Interv.
2009;2:428-34
•Choi et al. Circ Cardiovasc Interv
2011;4:239-47
•Sakurai et al. Am J Cardiol
2005;96:1251-3
•Liu et al.Am J Cardiol 2009;103:501-
6
•Costa et al, Am J Cardiol,
2008;101:1704-11
35. RESET trial
En el subgrupo de lesiones largas ( ≥28mm
longitud stent en vasos ≥2.5mm), los pacientes se
randomizaron a IVUS vs solo angiografia
Kim JS, JACC Cardiovasc Interv. 2013 Apr;6(4):369-76.
IVUS-
guidance
Angiography-
guidance
RR p
N 297 246
MACE (cardiac death,
MI, ST, TVR)
4.0% 8.1% 0.48 (0.23-0.99) 0.048
37. 225 patients with 233 coronary ostial lesions underwent
PCI with (n = 82) and without (n = 143) IVUS guidance.
After propensity score adjustment, IVUS use was associated with
significantly lower rates of the composite of cardiovascular death, MI, or
TLR, composite MI or TLR and MI compared with no IVUS.
The use of IVUS was also associated with a trend towards a lower rate of
TLR.
Conclusions: PCI of coronary ostial lesions with the use of
IVUS was associated with significantly lower rates of adverse
cardiac events
38. Randomized, multicentre, international, open label, investigator-driven study
evaluating IVUS vs angiographically guided DES implantation in patients with
complex lesions (defined as bifurcations, long lesions, chronic total occlusions or
small vessels).
The study included 284 patients.
The primary study end point (MLD stent) showed a statistically significant difference
in favor of the IVUS group (2.70 mm ± 0.46 mm vs. 2.51 ± 0.46 mm; P = .0002).
At 24-months clinical follow-up, no differences were still observed in cumulative
MACE (16.9%vs. 23.2 %)
CONCLUSIONS:
A benefit of IVUS optimized DES implantation was observed in complex lesions in
the post-procedure minimal lumen diameter. No statistically significant difference was
found in MACE up to 24 months
39.
40. Outcomes in 145 propensity-matched pairs of patients receiving
DES with and without IVUS guidance
Park S et al. Circ Cardiovasc Interv 2009;2:167-177
The Korean experience
IVUS guidance decreased mortality
Mortality
Death + MI TVR
41. Clinical impact of intravascular ultrasound
guidance in drug-eluting stent implantation for
unprotected left main coronary disease: pooled
analysis at patient level of 4 registries.
Jose M de la Torre Hernandez, MD, PhD, José Antonio Baz Alonso, MD, Joan Antoni
Gómez Hospital, MD, PhD, Fernando Alfonso, MD, PhD, Tamara Garcia Camarero,
MD, Federico Gimeno de Carlos, MD, PhD, Gerard Roura Ferrer, MD, Angel Sanchez
Recalde, MD, Íñigo Lozano Martínez-Luengas, MD, PhD, Josep Gomez Lara, MD,
Felipe Hernandez, MD, María José Pérez-Vizcayno, MD, Angel Cequier Fillat, MD,
PhD, Armando Perez de Prado, MD, Agustín Albarrán, MD, Manuel Jimenez Navarro,
MD, PhD, Josepa Mauri, MD, Jose A Fernandez Diaz, MD, Eduardo Pinar, MD, PhD,
Javier Zueco, MD
on behalf of the collaborative IVUS-TRONCO-ICP Spanish study
Clinical impact of intravascular ultrasound
guidance in drug-eluting stent implantation for
unprotected left main coronary disease: pooled
analysis at patient level of 4 registries.
Jose M de la Torre Hernandez, MD, PhD, José Antonio Baz Alonso, MD, Joan Antoni
Gómez Hospital, MD, PhD, Fernando Alfonso, MD, PhD, Tamara Garcia Camarero,
MD, Federico Gimeno de Carlos, MD, PhD, Gerard Roura Ferrer, MD, Angel Sanchez
Recalde, MD, Íñigo Lozano Martínez-Luengas, MD, PhD, Josep Gomez Lara, MD,
Felipe Hernandez, MD, María José Pérez-Vizcayno, MD, Angel Cequier Fillat, MD,
PhD, Armando Perez de Prado, MD, Agustín Albarrán, MD, Manuel Jimenez Navarro,
MD, PhD, Josepa Mauri, MD, Jose A Fernandez Diaz, MD, Eduardo Pinar, MD, PhD,
Javier Zueco, MD
on behalf of the collaborative IVUS-TRONCO-ICP Spanish study
De la Torre et al. JACC Intv. 2013 (Accepted, in press)
42. Registries pooled: Pts with DES in LM: F up:
ESTROFA-LM (770 pts in 21 centers) 3 yrs
RENACIMIENTO (596 pts in 30 centers) 1 yr
Bellvitge (189 pts in 1 center) 3 yrs
Valdecilla (200 pts in 1 center) 3 yrs
1.670 patients with PCI with DES in LM
505 patients under IVUS guidance (IVUS group)
Propensity score matched to:
505 patients without the use of IVUS (no-IVUS group)
55. Trombo RojoTrombo Rojo
Masa que protruyeMasa que protruye
con sombracon sombra
Trombo BlancoTrombo Blanco
Masa que protruyeMasa que protruye
sin sombrasin sombra
Sensibilidad: 95%
Especificidad: 88%
68. Methods
• Consecutive patients undergoing PCI with angiographic
plus OCT guidance (OCT group) at three high OCT-
volume Italian centers between 2009 and 2011 were
included.
• Patients in the OCT group (335 pts) were matched 1:1
with randomly-selected patients undergoing during the
same month PCI with angiographic only guidance
Angio group (335 pts).
70. Under-
expansion
In-stent MLA ≥90% of
the average reference
lumen area or ≥100% of
lumen area of the
reference segment with
the lowest lumen area
Thrombus
• > 200 µ
• lenght > 600
µ
77. Aleatorizados a:
IVUS = 35 pac
OCT = 35 pac
Aleatorizados a:
IVUS = 35 pac
OCT = 35 pac
Conclusions: FD-OCT guidance for stent implantation was associated
with smaller stent expansion and more frequent significant residual
reference segment stenosis compared with conventional IVUS guidance
Conclusions: FD-OCT guidance for stent implantation was associated
with smaller stent expansion and more frequent significant residual
reference segment stenosis compared with conventional IVUS guidance
78. Aun reconociendo la limitada evidencia
con IVUS, aun mas limitada con OCT,
ambas mejoran:
- La indicación de la ICP
- Los resultados “mecánicos” inmediatos y muy
probablemente los clínicos, especialmente en
lesiones de riesgo
(Tronco, Bifurcaciones, Reestenosis,...)
Aun reconociendo la limitada evidencia
con IVUS, aun mas limitada con OCT,
ambas mejoran:
- La indicación de la ICP
- Los resultados “mecánicos” inmediatos y muy
probablemente los clínicos, especialmente en
lesiones de riesgo
(Tronco, Bifurcaciones, Reestenosis,...)
EN CONCLUSIÓN